These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33318417)

  • 21. Role of hydrogen sulfide in secondary neuronal injury.
    Wang JF; Li Y; Song JN; Pang HG
    Neurochem Int; 2014 Jan; 64():37-47. PubMed ID: 24239876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydrogen sulfide alleviates oxidative stress injury and reduces apoptosis induced by MPP
    Liu L; Wang J; Wang H
    Mol Cell Biochem; 2020 Sep; 472(1-2):231-240. PubMed ID: 32577946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wnt/β-catenin signaling plays an essential role in α7 nicotinic receptor-mediated neuroprotection of dopaminergic neurons in a mouse Parkinson's disease model.
    Liu Y; Hao S; Yang B; Fan Y; Qin X; Chen Y; Hu J
    Biochem Pharmacol; 2017 Sep; 140():115-123. PubMed ID: 28551099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The proliferative capacity of the subventricular zone is maintained in the parkinsonian brain.
    van den Berge SA; van Strien ME; Korecka JA; Dijkstra AA; Sluijs JA; Kooijman L; Eggers R; De Filippis L; Vescovi AL; Verhaagen J; van de Berg WD; Hol EM
    Brain; 2011 Nov; 134(Pt 11):3249-63. PubMed ID: 22075520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced de novo neurogenesis and dopaminergic neurogenesis in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease-like mice.
    Shan X; Chi L; Bishop M; Luo C; Lien L; Zhang Z; Liu R
    Stem Cells; 2006 May; 24(5):1280-7. PubMed ID: 16424396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotective effects of ginsenoside Rg1 through the Wnt/β-catenin signaling pathway in both in vivo and in vitro models of Parkinson's disease.
    Zhou T; Zu G; Zhang X; Wang X; Li S; Gong X; Liang Z; Zhao J
    Neuropharmacology; 2016 Feb; 101():480-9. PubMed ID: 26525190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroprotective effects of hydrogen sulfide in Parkinson's disease animal models: methods and protocols.
    Xue X; Bian JS
    Methods Enzymol; 2015; 554():169-86. PubMed ID: 25725522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MK-801 (Dizocilpine) Regulates Multiple Steps of Adult Hippocampal Neurogenesis and Alters Psychological Symptoms via Wnt/β-Catenin Signaling in Parkinsonian Rats.
    Singh S; Mishra A; Srivastava N; Shukla S
    ACS Chem Neurosci; 2017 Mar; 8(3):592-605. PubMed ID: 27977132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotective properties of icariin in MPTP-induced mouse model of Parkinson's disease: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
    Chen WF; Wu L; Du ZR; Chen L; Xu AL; Chen XH; Teng JJ; Wong MS
    Phytomedicine; 2017 Feb; 25():93-99. PubMed ID: 28190476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson's disease: behavioral, histological and biochemical studies.
    Sarukhani M; Haghdoost-Yazdi H; Sarbazi Golezari A; Babayan-Tazehkand A; Dargahi T; Rastgoo N
    Neurol Res; 2018 Jul; 40(7):523-531. PubMed ID: 29726751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain-derived Neurotrophic Factor Promotes Growth of Neurons and Neural Stem Cells Possibly by Triggering the Phosphoinositide 3-Kinase/ AKT/Glycogen Synthase Kinase-3β/β-catenin Pathway.
    Li XT; Liang Z; Wang TT; Yang JW; Ma W; Deng SK; Wang XB; Dai YF; Guo JH; Li LY
    CNS Neurol Disord Drug Targets; 2017; 16(7):828-836. PubMed ID: 28524001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uric Acid Enhances Neurogenesis in a Parkinsonian Model by Remodeling Mitochondria.
    Lee JE; Shin YJ; Kim YS; Kim HN; Kim DY; Chung SJ; Yoo HS; Shin JY; Lee PH
    Front Aging Neurosci; 2022; 14():851711. PubMed ID: 35721028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydrogen Sulfide (H
    Aschner M; Skalny AV; Ke T; da Rocha JB; Paoliello MM; Santamaria A; Bornhorst J; Rongzhu L; Svistunov AA; Djordevic AB; Tinkov AA
    Curr Neuropharmacol; 2022; 20(10):1908-1924. PubMed ID: 35236265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Squamosamide derivative FLZ protected tyrosine hydroxylase function in a chronic MPTP/probenecid mouse model of Parkinson's disease.
    Bao XQ; Wu LY; Wang XL; Sun H; Zhang D
    Naunyn Schmiedebergs Arch Pharmacol; 2015 May; 388(5):549-56. PubMed ID: 25678053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
    Kanagaraj N; Beiping H; Dheen ST; Tay SS
    Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dihydromyricetin protects neurons in an MPTP-induced model of Parkinson's disease by suppressing glycogen synthase kinase-3 beta activity.
    Ren ZX; Zhao YF; Cao T; Zhen XC
    Acta Pharmacol Sin; 2016 Sep; 37(10):1315-1324. PubMed ID: 27374489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of adenosine triphosphate-sensitive potassium channels in the neuroprotective activity of hydrogen sulfide in the 6-hydroxydopamine-induced animal model of Parkinson's disease.
    Sarookhani MR; Haghdoost-Yazdi H; Sarbazi-Golezari A; Babayan-Tazehkand A; Rastgoo N
    Behav Pharmacol; 2018 Jun; 29(4):336-343. PubMed ID: 29239973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fasudil Enhances Therapeutic Efficacy of Neural Stem Cells in the Mouse Model of MPTP-Induced Parkinson's Disease.
    Li YH; Yu JW; Xi JY; Yu WB; Liu JC; Wang Q; Song LJ; Feng L; Yan YP; Zhang GX; Xiao BG; Ma CG
    Mol Neurobiol; 2017 Sep; 54(7):5400-5413. PubMed ID: 27590141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotection by tetrahydroxystilbene glucoside in the MPTP mouse model of Parkinson's disease.
    Zhang L; Huang L; Chen L; Hao D; Chen J
    Toxicol Lett; 2013 Oct; 222(2):155-63. PubMed ID: 23911879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.